Today

Agents

Chat

Arena

Discover

More

App

inTEST Corp Q2 Adjusted EPS USD 0.09 - INTT News | Rallies

inTEST Corp Q2 Adjusted EPS USD 0.09

INTT•2026-08-10

inTEST reports second-quarter results

Aug. 10 (Reuters) - inTEST Corp Q2 adjusted EBITDA margin 6.2%.

Q2 net income USD 474 thousand
Q2 operating income USD 363 thousand
Q2 revenue USD 35.313 million
Q2 gross margin 40.5%

Related News

Axsome Therapeutics Q2 revenue rises on AUVELITY growth

AXSM•2026-08-10

Aquestive posts Anaphylm study presentation on investor website

AQST•2026-08-10

BUZZ-AbCellera gains as experimental drug reduces hot flashes in mid-stage trial

2026-08-10

Lincoln Financial Announces Chief Financial Officer Transition

LNC•2026-08-10

Tenax Therapeutics' heart drug misses main goal in study, shares plunge

TENX•2026-08-10